Teva’s clinical research facilities adhere to applicable current Good Laboratory Practices (cGLP), and Good Clinical Practices (cGCP), and Teva’s sites in India have a successful regulatory inspection history and have been inspected multiple times by various global regulatory agencies and ministries of health.

While manufacturing is a key focus for Teva in India, it is by no means the company's sole focus in the country. Teva consistently taps India's strong R&D expertise, leveraging the availability of highly skilled technical staff at its research and development, clinical facilities, and global stability centres.

Teva has an active pharmaceutical ingredients R&D centre and a pharmaceutical formulation R&D site, which focuses on the development of generic medicines.

Share this article: